FIP Statement of policy: Pharmacist's authority in pharmaceutical product selection: therapeutic interchange and substitution

H Sasaki; LA Sheikh; A Vulto; A Bennett; Ross McKinnon; W Jama; M Andersson; M Ghalyini; D Van Broeck; R Yagudina; SG Chang; JM Oh; Z Kusynova

FIP Statement of policy: Pharmacist's authority in pharmaceutical product selection: therapeutic interchange and substitution

H Sasaki, LA Sheikh, A Vulto, A Bennett, Ross McKinnon, W Jama, M Andersson, M Ghalyini, D Van Broeck, R Yagudina, SG Chang, JM Oh, Z Kusynova

College of Medicine and Public Health

Research output: Book/Report › Commissioned report › peer-review

Abstract

The purpose of this document is to provide a set of recommendations on therapeutic interchange and substitution of pharmaceutical products, including with biosimilars.

Original language	English
Place of Publication	The Hague, Netherlands
Publisher	International Pharmaceutical Federation
Number of pages	7
Publication status	Published - 2 Sep 2018

Keywords

Policy statement
pharmaceutical selection
Drug selection
interchange
substitution
pharmacist

Access to Document

https://www.fip.org/file/2086Licence: In Copyright

Fingerprint Dive into the research topics of 'FIP Statement of policy: Pharmacist's authority in pharmaceutical product selection: therapeutic interchange and substitution'. Together they form a unique fingerprint.

Cite this

Sasaki, H., Sheikh, LA., Vulto, A., Bennett, A., McKinnon, R., Jama, W., Andersson, M., Ghalyini, M., Van Broeck, D., Yagudina, R., Chang, SG., Oh, JM., & Kusynova, Z. (2018). FIP Statement of policy: Pharmacist's authority in pharmaceutical product selection: therapeutic interchange and substitution. International Pharmaceutical Federation. https://www.fip.org/file/2086

Sasaki, H ; Sheikh, LA ; Vulto, A ; Bennett, A ; McKinnon, Ross ; Jama, W ; Andersson, M ; Ghalyini, M ; Van Broeck, D ; Yagudina, R ; Chang, SG ; Oh, JM ; Kusynova, Z. / FIP Statement of policy : Pharmacist's authority in pharmaceutical product selection: therapeutic interchange and substitution. The Hague, Netherlands : International Pharmaceutical Federation, 2018. 7 p.

@book{68741577380b40689837c428c73ae38e,

title = "FIP Statement of policy: Pharmacist's authority in pharmaceutical product selection: therapeutic interchange and substitution",

abstract = "The purpose of this document is to provide a set of recommendations on therapeutic interchange and substitution of pharmaceutical products, including with biosimilars.",

keywords = "Policy statement, pharmaceutical selection, Drug selection, interchange, substitution, pharmacist",

author = "H Sasaki and LA Sheikh and A Vulto and A Bennett and Ross McKinnon and W Jama and M Andersson and M Ghalyini and {Van Broeck}, D and R Yagudina and SG Chang and JM Oh and Z Kusynova",

year = "2018",

month = sep,

day = "2",

language = "English",

publisher = "International Pharmaceutical Federation",

}

Sasaki, H, Sheikh, LA, Vulto, A, Bennett, A, McKinnon, R, Jama, W, Andersson, M, Ghalyini, M, Van Broeck, D, Yagudina, R, Chang, SG, Oh, JM & Kusynova, Z 2018, FIP Statement of policy: Pharmacist's authority in pharmaceutical product selection: therapeutic interchange and substitution. International Pharmaceutical Federation, The Hague, Netherlands. <https://www.fip.org/file/2086>

FIP Statement of policy : Pharmacist's authority in pharmaceutical product selection: therapeutic interchange and substitution. / Sasaki, H; Sheikh, LA; Vulto, A; Bennett, A; McKinnon, Ross; Jama, W; Andersson, M; Ghalyini, M; Van Broeck, D; Yagudina, R; Chang, SG; Oh, JM; Kusynova, Z.

The Hague, Netherlands : International Pharmaceutical Federation, 2018. 7 p.

Research output: Book/Report › Commissioned report › peer-review

TY - BOOK

T1 - FIP Statement of policy

T2 - Pharmacist's authority in pharmaceutical product selection: therapeutic interchange and substitution

AU - Sasaki, H

AU - Sheikh, LA

AU - Vulto, A

AU - Bennett, A

AU - McKinnon, Ross

AU - Jama, W

AU - Andersson, M

AU - Ghalyini, M

AU - Van Broeck, D

AU - Yagudina, R

AU - Chang, SG

AU - Oh, JM

AU - Kusynova, Z

PY - 2018/9/2

Y1 - 2018/9/2

N2 - The purpose of this document is to provide a set of recommendations on therapeutic interchange and substitution of pharmaceutical products, including with biosimilars.

AB - The purpose of this document is to provide a set of recommendations on therapeutic interchange and substitution of pharmaceutical products, including with biosimilars.

KW - Policy statement

KW - pharmaceutical selection

KW - Drug selection

KW - interchange

KW - substitution

KW - pharmacist

M3 - Commissioned report

BT - FIP Statement of policy

PB - International Pharmaceutical Federation

CY - The Hague, Netherlands

ER -